The guide

Statins and other cholesterol medicines: the case for and against

By GyroscopeUpdated November 15, 202613 sources

If you take a cholesterol medicine, your prescriber decides any start, stop or change, so bring this page to them. Both sides are below, in numbers. Statins cut heart attacks and strokes by about a fifth for each 39 mg/dL off LDL, and the benefit in people is bigger the higher their risk. The side effects that blinded trials proved are real and uncommon, and most aches people blame on statins happened just as often on a placebo.

This guide helps you understand your numbers, do what you can with food, movement and habits, and walk into your doctor’s office knowing your options. If you want to try the natural way first, start with how to lower your cholesterol naturally. It isn’t medical advice, and we checked it against the 2026 ACC/AHA guideline and the Cholesterol Treatment Trialists’ reviews in November 2026.

Why it’s such a hard call

A statin sounds like a lifelong label, and stories about side effects travel faster than trial results. On the other side, a doctor sees heart attacks that a pill could have prevented. Both sides are looking at real things, and the trials let you put numbers on each.

Where the guideline draws the lines

Your doctor works out the 10-year risk with the PREVENT equations. This site never computes it.

The case for

They work, in proportion. A moderate statin lowers LDL 30 to 49% and a high-intensity one 50% or more. Across 26 trials and about 170,000 people, each 39 mg/dL off LDL cut heart attacks, strokes and artery procedures by about a fifth, and deaths from any cause by 10%. In 4S in 1994, deaths fell from 12% to 8% in people with heart disease.

The benefit in people depends on your risk. In a 2016 review, Rory Collins and colleagues worked it out: lowering LDL by 77 mg/dL for 5 years in 10,000 people would prevent major events in about 1,000 who already had artery disease, and about 500 who were at raised risk but hadn’t had an event yet. The benefit keeps growing each year a statin is taken.

They’re cheap. The same review put an effective dose of atorvastatin at about £2 a month in the UK, and the guideline notes that ezetimibe is a low-cost generic in the US.

Older people benefit too. In STAREE, published in August 2026, 9,971 people aged 70 and over without heart disease took atorvastatin or a placebo, and major heart events fell from 8.3% to 6.0%.

The case against, and what’s real

Some side effects are proven. Collins and colleagues counted them for 10,000 people treated for 5 years with atorvastatin 40 mg: about 5 cases of myopathy (muscle pain with a big rise in a muscle enzyme), 50 to 100 new cases of diabetes and 5 to 10 bleeding strokes. Genes that work like statins raise diabetes risk the same small way, and only in people whose blood sugar was already raised.

Muscle aches are real, and mostly not from the statin. In 19 double-blind trials of 123,940 people, 27.1% on a statin and 26.6% on a placebo reported muscle pain or weakness. In the first year, only about 1 in 15 of those reports on a statin were caused by it, and after the first year there was no difference.

The nocebo effect is strong. In SAMSON, 60 people who’d given up on statins took a year of statin months, placebo months and no-tablet months, without knowing which. Symptoms scored 16.3 in statin months, 15.4 in placebo months and 8.0 with no tablet, so about 90% of the symptoms came from taking a tablet at all. Six months later, half were back on a statin.

The absolute benefit is small at low risk. If your 10-year risk is low, a statin cuts a small number by a fifth, and you take a pill every day for years for it. That’s why the guideline leaves the decision to a talk at borderline and intermediate risk.

Benefit isn’t everything people hope. STAREE cut heart events in older people but didn’t help them live longer free of dementia and disability, and liver-related and diabetes-related problems were more common on atorvastatin.

Why open reports and trials disagree. Outside a blinded trial, everyone knows they’re on a statin, so every ache gets blamed on it. Blinded trials show which ones it caused. Collins and colleagues wrote that almost all the symptoms blamed on statins in routine practice aren’t caused by them.

The other medicines

The guideline adds ezetimibe, bempedoic acid or a PCSK9 antibody when lifestyle and a statin aren’t enough, depending on your risk.

Questions to take to your doctor

1. Which line in the guideline am I on, and what’s my 10-year risk on PREVENT?
2. What’s my LDL goal, and how far am I from it?
3. How much would a statin lower my risk, in people out of 100?
4. Could food changes close my gap first, and when would we retest?
5. Would a calcium scan or an ApoB or Lp(a) test change your advice?
6. If I start, which statin and dose, and when do we check my numbers again?
7. What should I do if I get aches or other side effects?
8. If a statin doesn’t suit me, which other medicine would you try?

Bring your last two panels and a list of everything you take. When medicine is the conversation to have and can I manage it with lifestyle? cover the rest.

If you take a cholesterol medicine, your prescriber sets your goal and decides any start, stop or change. Keep taking it, and bring your questions to them.